Stocks like Skinny, Eli Lilly’s Big FDA Move, & a Real Threat to Tech Titans?
CNBC
Stocks are rallying as the President proposes smaller, targeted relief aid but do investors believe this is real progress? We debate.
Plus, Eli Lilly has filed for FDA emergency use authorization of its Covid-19 antibody drug. We’ll speak with the CEO about the treatment, the potential timeline, and what production could look like.
And, in its lengthy report, Congress concludes four big tech giants have monopoly power and it’s time for changes. We look at what is likely to make its way into the bills as the real work begins.